Evidence map›Paper›PMID 31308862›Full record

ArticleThe Pan African medical journal2019

Factors associated with unfavourable tuberculosis treatment outcomes in Lusaka, Zambia, 2015: a secondary analysis of routine surveillance data.

Francis Hamaimbo Nanzaluka, Sylvia Chibuye, Clara Chola Kasapo, Nelia Langa, Sulani Nyimbili, Given Moonga, Nathan Kapata, Ramya Kumar, Gershom Chongwe

Abstract read
In one paragraph

Article in The Pan African medical journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Impact of HIV-AIDS on tuberculosis treatment outcome in Southern Ethiopia - A retrospective cohort study.Journal of clinical tuberculosis and other mycobacterial diseases · 2021
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Francis Hamaimbo NanzalukaField Epidemiology Training Programme, Lusaka, Zambia.
Sylvia ChibuyeMinistry of Health, Lusaka, Zambia.
Clara Chola KasapoMinistry of Health, Lusaka, Zambia.
Nelia LangaField Epidemiology Training Programme, Lusaka, Zambia.
Sulani NyimbiliMinistry of Health, Lusaka, Zambia.
Given MoongaUniversity of Zambia, Lusaka, Zambia.
Nathan KapataMinistry of Health, Lusaka, Zambia.
Ramya KumarZambart TB Project, Lusaka, Zambia.
Gershom ChongweUniversity of Zambia, Lusaka, Zambia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionFocus has been put on strengthening surveillance systems in high tuberculosis (TB) burden countries, like Zambia, however inadequate information on factors associated with unfavourable TB treatment outcomes is generated from the system. We determined the proportion of tuberculosis treatment outcomes and their associated factors.

methodsWe defined unfavourable outcome as death, lost-to-follow-up, treatment-failure, or not-evaluated and favourable outcome as a patient cured or completed-treatment. We purposively selected a 1

resultsWe included a total of 1,724 registered TB patients, from one urban clinic 694 (40%), a 1

conclusionUnfavourable TB treatment outcomes were high in the selected facilities. We recommend special attention to TB patients who are > 59 years old, TB relapses and TB / HIV co-infected. The national TB programme should strengthen close monitoring of health facilities in increasing efforts aimed at evaluating all the outcomes. Studies are required to identify and test interventions aimed at improving treatment outcomes.

Indexed as

Population SurveillanceAdolescentAdultAgedAged, 80 and overAge FactorsAntitubercular AgentsChildChild, PreschoolCoinfectionFemaleHIV InfectionsHumansInfantInfant, NewbornLogistic ModelsAntitubercular AgentsLusakaoutcomeSurveillancetreatmenttuberculosisZambia

Identifiers

PMID31308862
PMCPMC6609856

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.